StemCyte Provides Families Once-In-A-Lifetime Opportunity To Protect Child’s Long-Term Health


What if you could get a long-term health protection for your child’s future? Now with innovative technology provided by StemCyte child’s cord blood stem cells banking you can. Cord blood provides a rich source of stem cells. To date, more than 80 diseases have been successfully treated with stem cells. StemCyte gives parents a chance for healthy child insurance in the years to come. Learn more about cord blood banking and other offerings from StemCyte at the New York Baby Show coming up on May 14 and 15 at Pier 92!

The nation’s biggest show for expectant and new families, the New York Baby Show is a wonderful family-friendly mega-event featuring everything to do with maternity, baby, and toddler. From top products to trusted parenting experts, the New York Baby Show welcomes thousands of expectant and new parents from New York City, the Tri-State area, and beyond!

Tickets to the New York Baby Show are $30 per family, and $20 per individual.


We caught up with StemCyte team to learn more about what’s new with them and what parents can expect from them at the New York Baby Show!

 For someone unfamiliar with StemCyte, how would you describe the company’s mission and core offerings?

StemCyte is a global leading cord blood therapeutic company offers public and private cord blood banking. StemCyte is dedicated to helping the world’s physicians save more lives by providing high quality, safe and effective stem  cell transplantation and therapy to all patients in need.

What’s the background of the company? How has it evolved over time?

StemCyte began its Corporate “life” as a Public Umbilical Cord Blood (UCB) Bank with a mission to create the largest, most racially diverse UCB bank in the world to serve ALL patients in need. StemCyte has stayed true to this mission with its operations in the USA, Taiwan and India.  No other UCB bank has accomplished the diversity and treated as many patients around the world. StemCyte is truly an International UCB stem cell therapeutics company, having shipped over 2,000 UCB units from its Public bank to leading hospitals around the world.

The culture of StemCyte and the attitude of our employees is based on this mission, and the same is true in the USA, Taiwan, and India.  Because our “roots” are as a Public UCB Bank, we operate by the highest standards in the world and each unit that we collect and save – Public and Private – is treated in the same way, i.e. as if that specific unit will be used to save a life in the future.  The result is that StemCyte provides the BEST service to our customers and gives them the most peace of mind and confidence that their child’s UCB is being handled by the best UCB professionals in the world.

What are the most popular products and newest products relevant to families offered from Stemcyte?

StemCyte currently offers cord blood banking at costs starting at $1195 with an annual storage fee of $150 per year, and cord blood and cord tissue banking costs starting at $1990 with an annual storage fee of $275 per year. StemCyte offers affordable payment plans which use the client’s own credit card to pay the initial enrollment fee over the course of 6 and 12 months. Stemcyte also offers a virtual baby shower program which gives family, friends, and co-workers of our clients the opportunity to donate towards the cost of banking. Our refer a friend program is also a great way to clients to pass on their positive experience with StemCyte by recommending StemCyte to their friends. When they do, they will receive either a free year of storage for themselves, give it as a gift to their friend or a $100 cash back when their friend banks with StemCyte.

What sets StemCyte apart from other companies?

The fact that we have a very large and diverse Public UCB Bank, a very valuable asset that StemCyte owns, has allowed us to develop an Advanced Therapeutics initiative and to partner with leading researchers and clinicians in the USA, Taiwan, HK, China and India.  This initiative has led to clinical trials to develop UCB to treat Thalassemia, chronic and acute stroke as well as chronic and acute spinal cord injury……and this is only the beginning.  No other UCB company in the world has a multinational presence and no other UCB company in the world can state that they have our three component business model.

What can parents except to see from Stemcyte at the New York Baby Show?

StemCyte cord blood specialists will be onsite on the date of the event and ready to answer any questions expectant parents might have regarding cord blood and / or cord tissue banking. Expectants can always call 866.389.4659 or visit for more information.

For more information, check out!